Vanberra Signal

MIRA Pharmaceuticals

Curated by Signal

Developer of cannabinoid-based therapeutics for chronic pain and anxiety

Overview

Developer of cannabinoid-based therapeutics for chronic pain and anxiety. It offers therapeutics that targets the CB1 and 2 receptors for the treatment of phobias, social anxiety disorder, PTSD, generalized anxiety disorder, and panic disorder.

Key facts

Founded
2020

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Online pharmacy for cannabis medical and recreational products

    Health TechnologyKenosha, United States
  • Predictive analytics platform for population health analytics

    Health TechnologyWashington, DC, United States
  • Online appointment booking platform with doctors

    Health TechnologySan Francisco, United States

About MIRA Pharmaceuticals

What does MIRA Pharmaceuticals do?

Developer of cannabinoid-based therapeutics for chronic pain and anxiety.

Where is MIRA Pharmaceuticals headquartered?

MIRA Pharmaceuticals is headquartered in Baltimore, United States.

When was MIRA Pharmaceuticals founded?

MIRA Pharmaceuticals was founded in 2020.

Which sector is MIRA Pharmaceuticals in?

MIRA Pharmaceuticals operates in Health Technology.

Who are MIRA Pharmaceuticals's competitors?

Companies similar to MIRA Pharmaceuticals include Lifted Made, Aegis Health Analytics, and Habbiton.